期刊文献+

不同剂量碘普罗胺对老年患者肾功能的影响 被引量:2

A Study on the Effect of Different Dosages of Iopromide on Renal Function in Old Patients
下载PDF
导出
摘要 目的:了解不同剂量的低渗性非离子型造影剂碘普罗胺(Ioprom ide)对老年病人肾功能的影响。方法:31例无肾病史、术前肾功能正常的患者依据接受造影剂的剂量不同分为两组。通过在术后第1天、5天测定血清尿素氮(BUN)、血清肌酐(Scr)及肌酐清除率(Ccr),观察使用非离子型造影剂碘普罗胺后患者的肾功能变化。结果:造影前及后1 d,5 d,两组病人间BUN,Scr和Ccr水平差异性均无显著(P>0.05)。术后1 d时,两组病人均出现Scr轻度升高、Ccr轻度降低,5 d时,则恢复到造影前水平。全部病例均无急性肾功能衰竭发生。结论:一次294 m l以内剂量的非离子型造影剂碘普罗胺对老年病人是相对安全的,应用后Scr,Ccr的轻度改变,在5 d内恢复至造影前水平,且在一定剂量范围内与造影剂剂量间无显著相关性。 Objective: To investigate the effect of iopromide, a kind of low osmolar and nonionic contrast media, on renal function in old patients. Methods: 31 old patients who would accept angiography and other percutaneous vascular intervention operations were selected and were divided into two groups according to the low or high dosage of contrast media. The renal function of these patients were normal before accepting Iopromide. Their serum creatinine (Scr), creatinine clearance rate (Ccr) and blood urine nitrogen were monitored on the first and fifth days after accepting Iopromide. Evaluation of renal function changes of these old patients was carried out. Results. After the use of iopromide, no remarkable difference of Scr or Ccr was observed in the two groups. All patients' Scr was elevated and Ccr decreased slightly on the first day, but the level retuned to normal on the fifth day. Acute renal function failure was not found in these patients. Conclusions: The changes of Scr and Ccr after the use of iopromide do not relate with the dosages of contrast media. The dosage of 294 ml once is comparatively safe for old patients.
作者 李凡 朱平
出处 《贵阳医学院学报》 CAS 2005年第4期315-317,共3页 Journal of Guiyang Medical College
关键词 肾病 造影剂 老年人 碘普罗胺 nephrosis contrast media aged iopromide
  • 相关文献

参考文献11

  • 1MacNeill BD,Harding SA,Bazari H,et al.Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography[J].Catheter Cardiovasc Interv,2003,60(4):458-461.
  • 2Murphy SW,Barrett BJ,Parfrey PS.Contrast nephropathy[J].J Am Soc Nephrol,2000,11:177-182.
  • 3Lin J,Bonventre JV.Prevention of radiocontrast nephropathy[J].Curr Opin Nephrol Hypertens,2005,14(2):105-110.
  • 4Aspelin P,Aubry P,Fransson SG,et al.Nephrotoxic effects in high-risk patients undergoing angiography[J].N Engl J Med,2003,348:491-499.
  • 5Berg KJ.Nephrotoxicity related to contrast media[J].Scand J Urol Nephrol,2000,34:5 317-5 322.
  • 6Barrett BJ, Parfrey PS.Contrast nephropathy in the patients with impaired renal function:High versus low osmolar media[J].Kidney Int,1992,41:1 274-1 279.
  • 7Levy EM,Viscoli CM,Horwitz RI.The effect of acute renal failure on mortality: a cohort analysis[J].JAMA,1996,275,1 489-1 494.
  • 8Lautin EM,Freeman NJ.Radiocontrast-associated renal dysfunction:a comparison of lower-osmolality and conventional high-osmolality contrast media[J].AJR Am J Roentgenol,1991,157(1):59-65.
  • 9Vassiliu P,Sava J,Toutouzas KG,et al.Is contrast as bad as we think?Renal function after angiographic embolization of injured patients[J].J Am Coll Surg,2002,194:142-146.
  • 10龚志华,向定成.非离子型造影剂对肾功能正常和肾功能不全患者肾功能的影响[J].临床心血管病杂志,2003,19(4):243-244. 被引量:10

二级参考文献1

共引文献9

同被引文献18

  • 1肖龙,黄湖辉.造影剂肾病的危险因素及预防[J].国外医学(泌尿系统分册),2004,24(4):566-568. 被引量:15
  • 2胡洁之,翁志蓬,刘杰明,潘石宏.低渗非离子型造影剂碘普罗胺的肾脏安全性评价[J].实用医技杂志,2005,12(04B):985-986. 被引量:6
  • 3陈朝英,曹力.造影剂相关性肾病[J].国际移植与血液净化杂志,2007,5(2):4-8. 被引量:6
  • 4吉俊,丁小强.造影剂肾病预防的研究进展[J].中国临床药学杂志,2007,16(4):262-266. 被引量:6
  • 5BRIGUORI C, AIROLDI F, MORICI N, et al. New pharmacological protocols to prevent or reduce contrast media nephropathy [ J]. Mineva Cardioangiol,2005, 53 ( 1 ) :49 - 58.
  • 6ASPELIN P, AUBRY P, FRANSSON SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography[ J]. N Engl J Med, 2003, 348(6) :491 -499.
  • 7LIN J, BONVENTRE JV. Prenvention of mdiocontrast nephropathy[J]. Curr Opin Nephyol Hypertens, 2005, 14(2) :105 - 110.
  • 8McCullough PA, Adam A, Becker CR, et 81. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol, 2006; 98 : 5K- 13K.
  • 9Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Cathet Cardiovasc Interven, 2001,52 : 409-416.
  • 10Mehran R, Aymonge D, Nikolsk YE, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention:development and initial validation. J Am CoU Cardiol, 2004,44 : 1393-1399.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部